Gesundheit Nordhessen Holding AG

Verified siteinfo

Germany Mönchebergstr. 41-43, 34125 Kassel, Germany

2 trials recruiting
Neuroblastoma · Nephroblastoma
Adults and children

About Specializations

Gesundheit Nordhessen Holding AG in Kassel, Germany specialises in clinical trials of conditions such as Neuroblastoma, Nephroblastoma, and other specialisations. This site conducts important research.

Main research areas of the site

Pediatric Oncology

The medical center is at the forefront of pediatric oncology, focusing on innovative treatments for childhood cancers. The center's research is particularly concentrated on Stage IV childhood renal tumors, aiming to improve outcomes for young patients with complex metastatic conditions.

Metastatic Rapid Response Rate (MetRR)
Pulmonary Response Rate (PRR)
Non-Pulmonary Metastasis Response Rate (NPRR)

Through its pioneering work, the center is advancing the understanding of metastatic responses in pediatric patients, contributing to the development of more effective preoperative treatment protocols.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Mönchebergstr. 41-4334125 KasselGermany

Open in maps ↗

Recruiting now: 2 trials
Conditions studied: 2
Partner status: Verified site

More sites in Kassel Germany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Neuroblastoma

Recruiting

Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

Registered drugNo placebo

Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Busulfan
Sponsor:Institut Gustave Roussy

Contact Research Centre

Nephroblastoma

Recruiting

Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

Registered drugNo placebo

Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Carboplatin
Sponsor:GPOH gGmbH

Contact Research Centre

Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites